RIO DE JANEIRO, BRAZIL - As the most ambitious inoculation initiative in history begins in an effort to combat the coronavirus pandemic, compensation for potential side-effects is a key issue as governments try to strike a balance between obtaining supplies of vaccines and protecting the public.
The dismay vented by Brazilian President Jair Bolsonaro over a vaccine maker’s refusal to be held responsible for potential side-effects revealed the tensions behind negotiations over nations’ vaccine procurement, with terms on indemnification being a significant battleground.
Many developed countries are willing to take on the risks and hold harmless vaccine makers . . .